A Phase 3 interventional study of bupropion and transdermal patch and transdermal patch and nicotine inhaler in Tobacco Use Disorder, sponsored by US Department of Veterans Affairs. Completed at 1 site in United States. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2008-04-04.
Sponsored by US Department of Veterans Affairs · Phase 3, Interventional, and Treatment
The primary objective of this study is to determine which is the better approach to smoking cessation in veterans: bupropion combined with transdermal nicotine or high dose nicotine replacement therapy (NRT) using transdermal nicotine combined with nicotine inhaler.
This study is a two-arm open-label, randomized controlled trial of bupropion combined with transdermal nicotine versus high dose NRT (transdermal nicotine and nicotine inhaler) with all subjects receiving a behavioral counseling program for smoking cessation.
988 studies on the registry are indexed under Tobacco Use Disorder; 125 are open to participants now.
Browse Tobacco Use Disorder studies →US Department of Veterans Affairs is the lead sponsor of 675 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Drug pages: Bupropion · Transdermal Patch Dosage Form · Skin Patch Dosage Form
Drug pages: Transdermal Patch Dosage Form · Skin Patch Dosage Form · Nicotine Inhaler
The record gives a start of Oct 2003 and a completion of Sep 2005. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Oct 2006. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
US Department of Veterans Affairs →